Table 2.
Gastrointestinal side effects of nintedanib in patients with idiopathic pulmonary fibrosis.
| Adverse events | Number | Incidence |
|---|---|---|
| Nausea | 25 | 32.5% |
| Nausea (Discontinuation) | 13 | 16.8% |
| Diarrhea | 27 | 35.1% |
| Diarrhea (Discontinuation) | 10 | 12.9% |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.